| 3/26/2019 | BKCVDDEMIGPV | Market Commentary: Allison Transmission oversubscribed; Endo, Par Pharma jump; Bed Bath & Beyond surges
|
| 3/15/2019 | BKCVDDEMIGPV | Market Commentary: Power Solutions carries over; SS&C Technologies, Par in focus; Community Health drops
|
| 3/14/2019 | BKCVDDEMIGPV | Market Commentary: SS&C Technologies, Endo price; Amkor, Ashton Woods trade up; funds add $1.04 billion
|
| 3/14/2019 | BKDDHY | Moody’s cuts Endo debt, rates revolver, notes Ba3
|
| 3/14/2019 | BKDDHY | S&P trims Endo International, rates Par Pharma notes B+
|
| 10/5/2015 | BK | S&P ups Par Pharmaceutical, withdraws ratings
|
| 5/20/2015 | BKHY | S&P puts Par Pharmaceuticals on positive watch
|
| 5/18/2015 | BK | Market Commentary: WideOpenWest, Aria Energy break; Par Pharmaceutical loans slide with acquisition by Endo
|
| 5/18/2015 | BKHY | Moody’s could lift Par Pharma
|
| 2/19/2015 | BK | Market Commentary: PetSmart, Par Pharmaceutical break; Waste Industries, Veresen, BATS, Healogics tweak deals
|
| 2/19/2015 | BK | Par Pharmaceutical cuts spread on term loan B-3 to Libor plus 325 bps
|
| 2/10/2015 | BK | Market Commentary: AssuredPartners breaks; Panda Temple, Par Pharmaceutical release talk; Healogics floats OID
|
| 2/10/2015 | BK | Par Pharmaceutical talks $425 million loan at Libor plus 375-400 bps
|
| 2/10/2015 | BKDDHY | Moody's changes Par to stable, rates add-on B1
|
| 2/9/2015 | BK | Market Commentary: Citgo Holding, Phoenix Services hit secondary; PetSmart reveals pricing guidance with launch
|
| 2/9/2015 | BKHY | S&P rates Par Pharma loan B
|
| 2/9/2015 | BK | Par Pharmaceutical readies launch of new loan for Tuesday
|
| 2/5/2014 | BK | Market Commentary: Par Pharma, SBA, Chrysler, Dunkin', NewPage, ExGen break; Ziggo, PeroxyChem, Bob's reworked
|
| 2/5/2014 | BK | Par Pharmaceutical firms $1.45 billion term loan at Libor plus 300 bps
|
| 2/3/2014 | BKDDHY | S&P cuts Par Pharmaceutical
|
| 1/30/2014 | BK | Moody's gives Par loan B1
|
| 1/29/2014 | BK | Par Pharmaceutical launches $395 million add-on term loan, repricing
|
| 1/29/2014 | BK | Market Commentary: Atrium, Mergermarket, National Mentor break; multiple primary deals see revisions emerge
|
| 1/28/2014 | BK | Par Pharmaceuticals to hold loan lender call on Wednesday
|
| 1/22/2014 | BKHY | S&P: Par Pharmaceutical on negative watch
|
| 1/21/2014 | BK | Par Pharmaceutical gets commitments for $505 million of debt financing
|
| 2/1/2013 | BK | Market Commentary: ABB Concise, Summit, Genesys, Hamilton Sundstrand, Go Daddy, Par Pharmaceutical, IMS break
|
| 1/31/2013 | BKHY | S&P rates Par loan B+
|
| 1/28/2013 | BK | Market Commentary: Ocwen Loan Servicing breaks; DineEquity tweaks deal; SESAC, Crossmark shutting early
|
| 1/28/2013 | BK | Par Pharmaceutical launches term loan repricing at Libor plus 325 bps
|
| 1/25/2013 | BK | Par Pharmaceutical to hold credit facility lender call on Monday
|
| 10/19/2012 | BKHY | S&P: Par Pharmaceuticals loan B+, notes B-
|
| 9/28/2012 | BK | Market Commentary: Calpine, Level 3, GNC, Univar, Tank Holding break; iStar down with refi; Transtar to shut early
|
| 9/18/2012 | BKHY | S&P: Par Pharmaceutical unchanged
|
| 9/17/2012 | BK | Market Commentary: Getty Images sets bank meeting; Par Pharma upsizes; LCDX unchanged during holiday session
|
| 9/17/2012 | BK | Par Pharmaceutical upsizes loan to $1.06 billion, tightens spread talk
|
| 9/7/2012 | BK | Par Pharmaceutical talks $980 million loan at Libor plus 425-450 bps
|
| 9/7/2012 | BK | Market Commentary: Chemtura softens with add-on; CNO, Burger King, Payless, Par Pharmaceutical set talk
|
| 9/6/2012 | BK | Moody's rates Sky Growth
|
| 9/6/2012 | BKHY | S&P rates Par Pharmaceuticals loan B+, notes B-
|
| 9/4/2012 | BK | Par Pharmaceutical sets Thursday launch for $1.13 billion facility
|
| 9/4/2012 | BK | Market Commentary: Claire's Stores rises with paydown; Valeant dips on acquisition; FoxCo, Ikaria set talk
|
| 8/31/2012 | BK | Market Commentary: Investors await pickup in primary activity with acquisition/LBO deals post-Labor Day
|
| 8/22/2012 | BK | Par Pharmaceutical $1.13 billion facility anticipated for September
|
| 8/2/2012 | BKHY | Par Pharma plans $1.13 billion loan, $490 million bridge for buyout
|
| 7/16/2012 | BK | Par Pharmaceutical plans new debt via three banks for buyout by TPG
|
| 11/18/2011 | BK | Par Pharmaceutical enters $450 million facility for Anchen purchase
|
| 8/24/2011 | BK | Par Pharmaceutical plans $450 million facility for Anchen purchase
|
| 8/24/2011 | BK | Market Commentary: Avis term loan B syndication may slide into September; Par Pharmaceutical readies deal
|
